RCM
LEGN icon

Raleigh Capital Management’s Legend Biotech LEGN Stock Holding History

Raleigh Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-89
Closed -$5.98K – 1142
2023
Q3 		$5.98K Hold
89
– – ﹤0.01% 654
2023
Q2 		$6.14K Buy
+89
New +$5.82K ﹤0.01% 601

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Raleigh Capital Management's LEGN Position: Q4 2023 in Review

Raleigh Capital Management sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 89 shares — an estimated $5.98K sold.

Raleigh Capital Management first reported a position in LEGN in Q2 2023 and held it in 2 quarters. The position peaked at $6.14K in Q2 2023. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Raleigh Capital Management reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Raleigh Capital Management sold 89 Legend Biotech shares in Q4 2023, an estimated $5.98K.
  • Raleigh Capital Management first reported a position in Legend Biotech in Q2 2023 and held it in 2 quarters.
  • Raleigh Capital Management's Legend Biotech position peaked at $6.14K in Q2 2023.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Raleigh Capital Management's 13F filing for Q4 2023, filed 21 Feb 2024.